10H-Phenothiazine, ar, ar′-(C
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) (b) (1) (2)
official document · source cfr-2024
225,069 document(s) from the ingested source(s); showing 100.
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) (b) (1) (2)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) (b) (1) (2)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) (3) (4) (5) (6) (7) (i) (ii) (iii) (8) (b) (1) Persons who manufacture or propose to manufacture 11-AA: (i) For use as an intermediate in the manufacture of polymers in an enclosed process when it is expected that the 11-AA will be fully polymerized during the manufacturing process, or (ii) For use as a component in photoprocessing solutions. (2) Persons who import or propose to import 11-AA: (i) For use as an intermediate in the manufacture of polymers in an enclosed process when it is expected that the 11-AA will be fully polymerized during the manufacturing process, or (ii) For use as a component in photoprocessing solutions. (3) Persons who process or propose to process 11-AA: (i) For use as an intermediate in the manufacture of polymers in an enclosed process when it is expected that the 11-AA will be fully polymerized during the manufacturing process, or (ii) For use as a component in photoprocessing solutions. (c) (1) Small manufacturers (includes importers) as described in § 704.3. (2) Small processors. (3) Persons described in § 704.5. (4) Persons who, at any time during the 3-year period ending July 22, 1986, manufactured, imported, or processed 11-AA: (i) For use as an intermediate in the manufacture of polymers in an enclosed process when it is expected that the 11-AA will be fully polymerized during the manufacturing process, or (ii) For use as a component in photoprocessing solutions. (d) (e) (2) Persons who initiated manufacturing, importing, or process
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new use is any use other than as. (i) An intermediate in the manufacture of polymers in an enclosed process when it is expected that the 11-aminoundecanoic acid will be fully polymerized during the manufacturing process, or (ii) A component in photoprocessing solutions. (b) (1) (i) (ii) (iii) (iv) (v) (vi) (2) [Reserved]
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 48
10 U.S.C. 281 allows States and units of local government, as defined in 10 U.S.C. 281, to purchase equipment suitable for counter-drug, homeland security, and emergency response activities through the Department of Defense. GSA, in coordination with the Secretary of Defense, produces and maintains a catalog in accordance with the procedures established by the Secretary of Defense. The catalog includes access to equipment available under FSS contracts. States and units of local government interested in using the 1122 program should contact their designated State point of contact.
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) (b) (1) (2) (3)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 47
ELTs that operate only on frequency 121.5 MHz will no longer be certified. The manufacture, importation, and sale of ELTs that operate only on frequency 121.5 MHz is prohibited beginning July 10, 2019. Existing ELTs that operate only on frequency 121.5 MHz must be operated as certified.
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 29
(a) (2) This section shall not apply to the following: (i) Solid or liquid mixtures containing less than 0.1 percent by weight or volume of 4-Nitrobiphenyl; methyl chloromethyl ether; bis-chloromethyl ether; beta-Naphthylamine; benzidine or 4-Aminodiphenyl; and (ii) Solid or liquid mixtures containing less than 1.0 percent by weight or volume of alpha-Naphthylamine; 3,′-Dichlorobenzidine (and its salts); Ethyleneimine; beta-Propiolactone; 2-Acetylaminofluorene; 4-Dimethylaminoazobenzene, or N-Nitrosodimethylamine. (b) (c) (1) (2) (ii) Employees exposed to 4-Nitrobiphenyl; alpha-Naphthylamine; 3,′-Dichlorobenzidine (and its salts); beta-Naphthylamine; benzidine; 4-Aminodiphenyl; 2-Acetylaminofluorene; 4-Dimethylaminoazo-benzene; and N-Nitrosodimethylamine shall be required to wash hands, forearms, face, and neck upon each exit from the regulated areas, close to the point of exit, and before engaging in other activities. (3) (4) (i) Access shall be restricted to authorized employees only. (ii) Each operation shall be provided with continuous local exhaust ventilation so that air movement is always from ordinary work areas to the operation. Exhaust air shall not be discharged to regulated areas, nonregulated areas or the external environment unless decontaminated. Clean makeup air shall be introduced in sufficient volume to maintain the correct operation of the local exhaust system. (iii) Employees shall be provided with, and required to wear, clean, full body protective clothin
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 29
The publisher provides no abstract for this document; none is invented here.
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 29
The publisher provides no abstract for this document; none is invented here.
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 21
(a) (b) (2) Authorization for this use shall not be construed as waiving any of the requirements of sections 510(k), 515, and 520(g) of the Federal Food, Drug, and Cosmetic Act with respect to the contact lens in which the color additive is used. (c) (d)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 21
(a) (b) (2) Authorization for this use shall not be construed as waiving any of the requirements of sections 510(k), 515, and 520(g) of the Federal Food, Drug, and Cosmetic Act with respect to the contact lens in which the color additive is used. (c) (d)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 47
Mutually exclusive initial applications for the 1670-1675 MHz Band license are subject to competitive bidding. The general competitive bidding procedures set forth in part 1, subpart Q of this chapter will apply unless otherwise provided in this subpart.
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 47
Mutually exclusive initial applications for 1695-1710 MHz, 1755-1780 MHz, and 2155-2180 MHz band licenses are subject to competitive bidding. The general competitive bidding procedures set forth in 47 CFR part 1, subpart Q will apply unless otherwise provided in this subpart.
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 21
(a) (b)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 21
(a) (b)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 21
(a) (b)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) (b) (1) (2)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 47
Mutually exclusive initial applications for 1710-1755 MHz and 2110-2155 MHz band licenses are subject to competitive bidding. The general competitive bidding procedures set forth in 47 CFR part 1, subpart Q will apply unless otherwise provided in this subpart.
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 47
Mutually exclusive initial applications for 1915-1920 MHz and 1995-2000 MHz band licenses are subject to competitive bidding. The general competitive bidding procedures set forth in 47 CFR part 1, subpart Q will apply unless otherwise provided in this subpart.
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 20
(a) The 1937 Act LSDP is payable in the following order and amounts: (1) The employee's “living with” widow(er) is paid the total amount of the LSDP. (Refer to § 234.21 for an explanation of “living with.”) (2) A funeral home, which has unpaid expenses, is paid the amount of the unpaid expenses or the total amount of the LSDP, whichever is less. (3) An equitably entitled person is paid the total amount of the LSDP or a proportionate share of the LSDP, depending upon the amount of burial expenses he or she paid. (b) The 1937 Act LSDP is equal to ten times the basic amount. (Refer to § 234.20 for an explanation of the computation of the employee's basic amount.)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 13
A 1940 Act or 1980 Act Company is eligible to apply for an SBIC license, and an existing Licensee is eligible to apply for SBA's approval to convert to a 1940 Act or 1980 Act Company. In either case, the 1940 Act or 1980 Act Company may elect to be taxed as a regulated investment company under section 851 of the Internal Revenue Code of 1986, as amended (26 U.S.C. 851). However, a Licensee making such election may make Distributions only as permitted under the applicable sections of this part (see the definition of Retained Earnings Available for Distribution, § 107.585, and §§ 107.1540 through 107.1580).
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 20
(a) The total amount of the 1974 Act LSDP is payable to the employee's widow(er), if she or he was “living in the same household” as the employee at the time of the employee's death. (Refer to § 234.21 for an explanation of “living in the same household.”) (b) The amount of the 1974 Act LSDP is equal to three times the amount of the PIA, as determined by section 215 of the Social Security Act, or $255.00, whichever is less.
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 20
(a) (1) You must— (i) Have one “quarter of coverage” (see §§ 404.101 and 404.110 of this part) before 1951; (ii) Have attained age 21 after 1936 and before 1950, or attained age 22 after 1950 and earned fewer than 6 quarters of coverage after 1950; (iii) Have not had a period of disability which began before 1951, unless it can be disregarded, as explained in § 404.320 of this part; and, (iv) Have attained age 62, become disabled, or died, after 1977. (2)(i) You or your survivor becomes entitled to benefits for June 1992 or later; (ii) You do not meet the conditions in paragraph (a)(1) of this section, and, (iii) No person is entitled to benefits on your earnings record in the month before the month you or your survivor becomes entitled to benefits. (3) A recomputation is first effective for June 1992 or later based on your earnings for 1992 or later. (b) (2) Next, we compute your average monthly wage, as described in paragraph (d) of this section. (3) Next, we apply the old-start formula to your average monthly wage, as described in paragraph (e)(1) of this section. (4) Next, we apply certain increments to the amount computed in step (3), as described in paragraph (e)(2) of this section. (5) Next, we find your primary insurance amount in the benefit table in appendix III, as described in paragraph (f)(1) of this section. (6) Then, we apply automatic cost-of-living or (c) (i) If you reached age 21 before 1950 and your total 1937-1950 earnings (ii) If you reached age 21 before
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (i) Allowable SO (ii) Citation of statute, regulations, and any other authority under which the allowable emissions rate under paragraph (a)(1) of this section is established as applicable to the combustion source; (iii) Averaging time associated with the allowable emissions rate under paragraph (a)(1) of this section. (iv) The annualization factor for the combustion source, based on the type of combustion source and the associated averaging time of the allowable emissions rate of the combustion source, as set forth in the Table 2 of this section: (2) (ii) For combustion sources that commenced operation after January 1, 1985, the calendar year for the allowable SO (iii) For combustion sources meeting the requirements of § 74.20(c), the calendar year for calculating the allowable SO (b)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) EPA approves as a revision to the Alaska State Implementation Plan the 1990 Base Year Carbon Monoxide Emission Inventory for the Anchorage and Fairbanks areas designated as nonattainment for CO, submitted by the Alaska Department of Environmental Conservation on December 29, 1993. This submittal consists of the 1990 base year stationary, area, non-road mobile, and on-road mobile sources for the pollutant carbon monoxide. (b) EPA approves a revision to the Alaska State Implementation Plan, submitted on December 5, 1994, of the on-road mobile source portion of the 1990 Base Year Emission Inventory for Carbon Monoxide in Anchorage and Fairbanks.
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) (iii) (b) (1) (2)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) (b) (1) (2)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) (b) (1) (2)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) [Reserved] (b) (1) (2)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) [Reserved] (b) (1) (2) (3)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) [Reserved] (b) (1) (2)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) [Reserved] (b) (1) (2)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) (b) (1) (2)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) (b) (1) (2) (3)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (b) (c) (d)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
2,2,5-trimethyl-3-dichloroacetyl-1,3-oxazolidine is exempted from the requirement of a tolerance when used as an inert ingredient in formulations of the herbicides
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) [Reserved] (b) (1) (2)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 21
(a) (b)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) After January 6, 2026, all persons are prohibited from all processing and distribution in commerce of 2,4,6-TTBP oil and lubricant additives at any concentration above 0.3 percent by weight. (b)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) (iii) (b) (1) (2) (3)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) (b) (1) (2)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (b) (c) (d)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (b) (c) (d)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) (b) (1) (2)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) (b) (1) (2)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) (b) (1) (2)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) (iii) (b) (1) (2) (3)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) [Reserved] (b) (1) (2)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) (b) (1) (2)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) [Reserved] (b) (1) (2)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) (b) (1) (2)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) [Reserved] (b) (1) (2)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) [Reserved] (b) (1) (2)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (b) (c) (d)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) (b) (1) (2)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) [Reserved] (b) (1) (2)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) [Reserved] (b) (1) (2)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) [Reserved] (b) (1) (2)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (b) (c) (d)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 29
See § 1910.1003,
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 29
The publisher provides no abstract for this document; none is invented here.
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 29
The publisher provides no abstract for this document; none is invented here.
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) (b) (1) (2)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
The inert ingredient, 2-amino-4,5-dihydro-6-methyl-4-propyl-s-triazolo(1,5-alpha)pyrimidin-5-one is
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) (iii) (iv) (b) (1) (2) (3)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) (b) (1) (2)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) [Reserved] (b) (1) (2)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) (iii) (iv) (b) (1) (2)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) (b) (1) (2)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) (b) (1) (2)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) (iii) (b) (1) (2)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) (iii) (b) (1) (2)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 7
(a) (b) (c)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new use is domestic use in a consumer product or the manufacture or import of 2-methoxyethanol acetate at levels greater than 10,000 pounds per year. (b) (1) (2) [Reserved]
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) [Reserved] (b) (1) (2)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) 2-Ethylhexanol of at least 99.0-percent purity shall be used as the test substance. (b) (c) (B) For the purpose of this section, the following provisions also apply to the oncogenicity tests: ( ( (ii) (B) The oncogenicity testing shall be completed and final report submitted to the Agency within 53 months of the effective date of this final rule if 2-ethylhexanol is administered by gavage or within 56 months of the effective date of this final rule if administered by microencapsulation. (C) Interim progress reports shall be submitted to EPA at 6-month intervals beginning 6 months after the effective date of the final rule, until the final report is submitted to EPA. (2) [Reserved] (d)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (A) NIOSH-certified powered air-purifying respirator with a tight-fitting half mask and HEPA filters. (B) NIOSH-certified continuous flow supplied-air respirator equipped with a tight-fitting half mask. (C) NIOSH-certified negative pressure (demand) supplied-air respirator equipped with a full facepiece. (ii) (b) (1) (2)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) (iii) (b) (1) (2)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) [Reserved] (b) (1) (2)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 21
(a) (b) (c) (2) (3)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) MBT of at least 97.6 percent purity (plus or minus 1.5 percent) shall be used as the test substance. (b) (c) (ii) (B) An interim progress report shall be submitted to EPA 6 months after the effective date of the final rule. (2) (ii) (B) An interim progress report shall be submitted to EPA 6 months after the effective date of the final rule. (3) (ii) (B) An interim progress report shall be submitted to EPA 6 months after the effective date of this final rule. (d) (B) For the purpose of this section, the following provisions also apply: ( ( ( ( ( ( ( ( (ii) (B) An interim progress report shall be submitted to EPA 6 months after the effective date of the final rule. (2) (B) For the purposes of this section, the following provisions also apply: ( ( ( (ii) (B) An interim progress report shall be submitted to EPA 6 months after the effective date of the final rule. (e) (ii) (B) An interim progress report shall be submitted to EPA 6 months after the effective date of the final rule. (2) (ii) (B) Progress reports shall be submitted to EPA at 6-month intervals beginning 6 months after the effective date of the final rule until submission of the final report. (3) ( ( ( (B)( ( ( ( (C)( ( ( ( (ii) (B) A progress report shall be submitted to EPA for the functional observation battery, motor activity, and neuropathology tests, respectively, 6 months after the effective date of the final rule. (4) (B) A heritable translocation assay shall be conducted with MBT in accordance with the
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) [Reserved] (b) (1) (2)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) [Reserved] (b) (1) (2)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) [Reserved] (b) (1) (2)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) [Reserved] (b) (1) (2)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) [Reserved] (b) (1) (2)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) (iii) (b) (1) (2) (3)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (A) NIOSH-certified air-purifying, tight-fitting half-face respirator equipped with N100 (if oil aerosols absent), R100, or P100 filters; (B) NIOSH-certified air-purifying, tight-fitting full-face respirator equipped with N100 (if oil aerosols absent), R100, or P100 filters; (C) NIOSH-certified powered air-purifying respirator equipped with a loose-fitting hood or helmet and high efficiency particulate air (HEPA) filters; (D) NIOSH-certified powered air-purifying respirator equipped with a tight-fitting facepiece (either half-face or full-face) and HEPA filters; and (E) NIOSH-certified supplied-air respirator operated in pressure demand or continuous flow mode and equipped with a hood or helmet, or tight-fitting facepiece (either half-face or full-face). (ii) (b) (1) (2)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) (iii) (b) (1) (2) (3)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) (b) (1) (2)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) (iii) (iv) (b) (1) (2) (3)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) (iii) (b) (1) (2) (3)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) (iii) (b) (1) (2) (3)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) (iii) (b) (1) (2)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) [Reserved] (b) (1) (2)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) (iii) (b) (1) (2) (3)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) (iii) (b) (1) (2) (3)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) [Reserved] (b) (1) (2)
official document · source cfr-2024
CFR · 2024-01-01 · US · Title 40
(a) (2) The significant new uses are: (i) (ii) (b) (1) (2)
official document · source cfr-2024